BioAffinity Technologies Inc. (BIAF)
NASDAQ · Healthcare
BioAffinity Technologies Inc. EBITDA 2022–2025
BioAffinity Technologies Inc. annual/quarterly ebitda history and growth rate from 2022 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- BioAffinity Technologies Inc. ebitda for the quarter ending March 31, 2026 was -3.5 M, a 41.65% increase year-over-year.
- BioAffinity Technologies Inc. ebitda for the twelve months ending March 31, 2026 was -10.6 M, a 35.49% increase year-over-year.
- BioAffinity Technologies Inc. annual ebitda for 2025 was -10.1 M, a 20.60% increase from 2024.
- BioAffinity Technologies Inc. annual ebitda for 2024 was -8.3 M, a 8.08% increase from 2023.
- BioAffinity Technologies Inc. annual ebitda for 2023 was -7.7 M, a 93.05% increase from 2022.
- BioAffinity Technologies Inc. annual ebitda for 2022 was -4.0 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
BioAffinity Technologies Inc. EBITDA — FAQ
BioAffinity Technologies Inc. (BIAF) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIAF's ebitda history?
The chart and table above show BioAffinity Technologies Inc.'s ebitda by year and by quarter, including the growth rate.